ArticleChemistry & biodiversity2025
Bioactive Compound Characterization and Phytopharmacological Potentials of Tulbaghia violacea Fruits and Seeds.
Article in Chemistry & biodiversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tulbaghia violacea is an established medicinal plant that is indigenous to southern Africa. All its plant parts have been profiled for their phytochemical constituents and medicinal potentials except for the seeds and fruits. Thus, this study assessed the seeds (air-dried) and fruits (freeze-dried), extracted with six solvents, for their bioactive compounds, antioxidant capacities, and antibacterial activities. All the 10 tested phytochemicals were detected across the six solvents, with more phytochemicals detected in the fruits. The fruit aqueous extract gave the highest yield (37.4%), while the hexanoic fruit extract had the lowest extraction yield (3.27%). The fruit had higher phenolic content across the solvents except in methanol. Conversely, except in hexanoic extracts, the seed had higher total proanthocyanidin contents across the solvents. In addition, the fruit had a higher total antioxidant capacity than the seeds, similar to the observation in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. T. violacea fruit and seeds showed antibacterial activity against Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis, but this activity was dose-dependent. However, neither the fruit nor the seed extract had any antibacterial effect on Klebsiella pneumoniae. This study showed that T. violacea fruits and seeds may be additional resources with medicinal benefits for human use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.